Guardian Pharmacy Services, Inc. Share-based Payment Arrangement, Expense
Guardian Pharmacy Services, Inc. (GRDN) reported Share-based Payment Arrangement, Expense of $13.85 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-11
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $1.08M, a 68.80% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $4.36M, a 96.44% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $4.45M.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $3.97M, a 33.25% decline year-over-year.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for fiscal 2025 was $13.85M, a 89.47% decline from fiscal 2024.
- Guardian Pharmacy Services, Inc. share-based payment arrangement, expense for fiscal 2024 was $131.49M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $5.44M derived: sum of 2 quarters · filed 2026-03-11 | $9.88M derived: sum of 3 quarters · filed 2026-03-11 | $13.85M 10-K · filed 2026-03-11 |
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-10 | $8.80M derived: sum of 2 quarters · filed 2025-11-10 | $12.77M 10-Q · filed 2025-11-10 | $16.23M derived: sum of 4 quarters · filed 2026-03-11 |
| 2025-06-30 | $4.45M 10-Q · filed 2025-08-11 | $8.41M 10-Q · filed 2025-08-11 | $11.88M derived: sum of 3 quarters · filed 2026-03-11 | $134.23M derived: sum of 4 quarters · filed 2026-03-11 |
| 2025-03-31 | $3.97M 10-Q · filed 2025-05-12 | $7.43M derived: sum of 2 quarters · filed 2026-03-11 | $129.78M derived: sum of 3 quarters · filed 2026-03-11 | $129.51M derived: sum of 4 quarters · filed 2026-03-11 |
| 2024-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $125.82M derived: sum of 2 quarters · filed 2026-03-11 | $125.54M derived: sum of 3 quarters · filed 2026-03-11 | $131.49M 10-K · filed 2026-03-11 |
| 2024-09-30 | $122.36M 10-Q · filed 2025-11-10 | $122.08M derived: sum of 2 quarters · filed 2025-11-10 | $128.03M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$272.00K 10-Q · filed 2025-08-11 | $5.67M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $5.95M 10-Q · filed 2025-05-12 |